Gut microbiota: Association with NAFLD and metabolic disturbances

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Lau, E ^a   Carvalho, D ^a   Freitas, P ^a  

^a Universidade do Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; PROBIOTIC AGENT;

ALCOHOL PRODUCTION; ALLISONELLA; ANAEROSPOROBACTER; BACTEROIDES UNIFORMIS; BIFIDOBACTERIUM LONGUM; DYSLIPIDEMIA; FAECALIBACTERIUM; GAMMAPROTEOBACTERIA; HUMAN; IMMUNOREGULATION; INFLAMMATION; INSULIN RESISTANCE; INTESTINE FLORA; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PARABACTEROIDES; PATHOGENESIS; REVIEW; HOST PATHOGEN INTERACTION; LIVER; METABOLIC SYNDROME X; METABOLISM; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY;

GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIVER; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84930959571     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/979515     Document Type: Review

References (50)

1. N. Sattar, E. Forrest, and D. Preiss, "Non-alcoholic fatty liver disease, " British Medical Journal, vol. 349, Article ID g4596, 2014.
2. G. Vernon, A. Baranova, and Z. M. Younossi, "Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, " Alimentary Pharmacology and Therapeutics, vol. 34, no. 3, pp. 274-285, 2011.
3. R. Vuppalanchi and N. Chalasani, "Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management, " Hepatology, vol. 49, no. 1, pp. 306-317, 2009.
4. J. K. Dowman, J. W. Tomlinson, and P. N. Newsome, "Pathogenesis of non-alcoholic fatty liver disease, " QJM, vol. 103, no. 2, pp. 71-83, 2010.
5. C. P. Day and O. F. W. James, "Steatohepatitis: a tale of two hits?" Gastroenterology, vol. 114, no. 4, pp. 842-845, 1998.
6. J. Qin, R. Li, J. Raes et al., "Ahuman gut microbial gene catalogue established by metagenomic sequencing, " Nature, vol. 464, no. 7285, pp. 59-65, 2010.
7. S. Prakash, L. Rodes, M. Coussa-Charley, and C. Tomaro-Duchesneau, "Gut microbiota: next frontier in understanding human health and development of biotherapeutics, " Biologics, vol. 5, pp. 71-86, 2011.
8. R. E. Ley, F. Backhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight, and J. I. Gordon, "Obesity alters gut microbial ecology, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 31, pp. 11070-11075, 2005.
9. R. E. Ley, P. J. Turnbaugh, S. Klein, and J. I. Gordon, "Microbial ecology: human gut microbes associated with obesity, " Nature, vol. 444, no. 7122, pp. 1022-1023, 2006.
10. M. Vijay-Kumar, J. D. Aitken, F. A. Carvalho et al., "Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5, " Science, vol. 328, no. 5975, pp. 228-231, 2010.
11. F. Backhed, H. Ding, T. Wang et al., "The gut microbiota as an environmental factor that regulates fat storage, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 44, pp. 15718-15723, 2004.
12. W. Z. Mehal, "The Gordian Knot of dysbiosis, obesity and NAFLD, " Nature Reviews Gastroenterology and Hepatology, vol. 10, no. 11, pp. 637-644, 2013.
13. D. Compare, P. Coccoli, A. Rocco et al., "Gut-liver axis: the impact of gut microbiota on non alcoholic fatty liver disease, " Nutrition, Metabolism and Cardiovascular Diseases, vol. 22, no. 6, pp. 471-476, 2012.
14. V. W.-S. Wong, C.-H. Tse, T. T.-Y. Lamet al., "Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis-a longitudinal study, " PLoS ONE, vol. 8, no. 4, Article ID e62885, 2013.
15. L. Zhu, S. S. Baker, C. Gill et al., "Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH, " Hepatology, vol. 57, no. 2, pp. 601-609, 2013.
16. M. Raman, I. Ahmed, P. M. Gillevet et al., "Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease, " Clinical Gastroenterology and Hepatology, vol. 11, no. 7, pp. 868-875. e3, 2013.
17. M. D. Spencer, T. J. Hamp, R. W. Reid, L. M. Fischer, S. H. Zeisel, and A. A. Fodor, "Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency, " Gastroenterology, vol. 140, no. 3, pp. 976-986, 2011.
18. A. Alisi, G. Bedogni, G. Baviera et al., "Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis, " Alimentary Pharmacology and Therapeutics, vol. 39, no. 11, pp. 1276-1285, 2014.
19. M. Malaguarnera, M. Vacante, T. Antic et al., "Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis, " Digestive Diseases and Sciences, vol. 57, no. 2, pp. 545-553, 2012.
20. S. deMinicis, C. Rychlicki, L. Agostinelli et al., "Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice, " Hepatology, vol. 59, no. 5, pp. 1738-1749, 2014.
21. J. Henao-Mejia, E. Elinav, C. Jin et al., "Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity, " Nature, vol. 482, no. 7384, pp. 179-185, 2012.
22. T. le Roy, M. Llopis, P. Lepage et al., "Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice, " Gut, vol. 62, no. 12, pp. 1787-1794, 2013.
23. N. deWit, M. Derrien, H. Bosch-Vermeulen et al., "Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 303, no. 5, pp. G589-G599, 2012.
24. M.-E. Dumas, R. H. Barton, A. Toye et al., "Metabolic profiling reveals a contribution of gutmicrobiota to fatty liver phenotype in insulin-resistant mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 33, pp. 12511-12516, 2006.
25. A. M. Neyrinck, S. Possemiers, W. Verstraete, F. de Backer, P. D. Cani, and N. M. Delzenne, "Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp. ) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice, " Journal of Nutritional Biochemistry, vol. 23, no. 1, pp. 51-59, 2012.
26. Y. Ritze, G. Bardos, A. Claus et al., "Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice, " PLoS ONE, vol. 9, no. 1, Article ID e80169, 2014.
27. H. Okubo, H. Sakoda, A. Kushiyama et al., "Lactobacillus casei strain shirota protects against nonalcoholic steatohepatitis development in a rodent model, " The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 305, no. 12, pp. G911-G918, 2013.
28. X. Yin, J. Peng, L. Zhao et al., "Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula, " Systematic and Applied Microbiology, vol. 36, no. 3, pp. 188-196, 2013.
29. P. G. Cano, A. Santacruz, A. Moya, andY. Sanz, "Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity, " PLoS ONE, vol. 7, no. 7, Article ID e41079, 2012.
30. B. D. Pachikian, A. Essaghir, J.-B. Demoulin et al., "Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways, " Molecular Nutrition and Food Research, vol. 57, no. 2, pp. 347-359, 2013.
31. S. Wagnerberger, A. Spruss, G. Kanuri et al., "Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis, " British Journal of Nutrition, vol. 107, no. 12, pp. 1727-1738, 2012.
32. A. Mencin, J. Kluwe, and R. F. Schwabe, "Toll-like receptors as targets in chronic liver diseases, " Gut, vol. 58, no. 5, pp. 704-720, 2009.
33. A. Spruss, G. Kanuri, S. Wagnerberger, S. Haub, S. C. Bischoff, and I. Bergheim, "Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice, " Hepatology, vol. 50, no. 4, pp. 1094-1104, 2009.
34. D. A. Brenner, E. Seki, K. Taura et al., "Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase, " Hepatology Research, vol. 41, no. 7, pp. 683-686, 2011.
35. A. J. Wigg, I. C. Roberts-Thomson, R. B. Dymock, P. J. McCarthy, R. H. Grose, and A. G. Cummins, "The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis, " Gut, vol. 48, no. 2, pp. 206-211, 2001.
36. L. Miele, V. Valenza, G. la Torre et al., "Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease, " Hepatology, vol. 49, no. 6, pp. 1877-1887, 2009.
37. D. P. Clark, "The fermentation pathways of Escherichia coli, " FEMS Microbiology Reviews, vol. 63, no. 3, pp. 223-234, 1989.
38. T. Sarkola and C. J. P. Eriksson, "Effect of 4-methylpyrazole on endogenous plasma ethanol and methanol levels in humans, " Alcoholism: Clinical and Experimental Research, vol. 25, no. 4, pp. 513-516, 2001.
39. P. D. Cani, R. Bibiloni, C. Knauf et al., "Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice, " Diabetes, vol. 57, no. 6, pp. 1470-1481, 2008.
40. L. Peng, Z.-R. Li, R. S. Green, I. R. Holzman, and J. Lin, "Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers, " Journal of Nutrition, vol. 139, no. 9, pp. 1619-1625, 2009.
41. W. Scheppach, P. Bartram, A. Richter et al., "Effect of shortchain fatty acids on the human colonicmucosa in vitro, " Journal of Parenteral and EnteralNutrition, vol. 16, no. 1, pp. 43-48, 1992.
42. J. Lee, S.-W. Hong, E.-J. Rhee, and W.-Y. Lee, "GLP-1 receptor agonist and non-alcoholic fatty liver disease, " Diabetes and Metabolism Journal, vol. 36, no. 4, pp. 262-267, 2012.
43. Z. M. Younossi, M. Stepanova, M. Afendy et al., "Changes in the prevalence of the most common causes of chronic liver diseases in theUnited States from1988 to 2008, " Clinical Gastroenterology and Hepatology, vol. 9, no. 6, pp. 524e. 1-530. e1, 2011.
44. P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, "An obesity-associated gut microbiome with increased capacity for energy harvest, " Nature, vol. 444, no. 7122, pp. 1027-1031, 2006.
45. P. Paschos and K. Paletas, "Non alcoholic fatty liver disease and metabolic syndrome, " Hippokratia, vol. 13, no. 1, pp. 9-19, 2009.
46. P. D. Cani, J. Amar, M. A. Iglesias et al., "Metabolic endotoxemia initiates obesity and insulin resistance, " Diabetes, vol. 56, no. 7, pp. 1761-1772, 2007.
47. J.-M. Sabate, P. Jouet, F. Harnois et al., "High prevalence of small intestinal bacterial overgrowth in patients withmorbid obesity: a contributor to severe hepatic steatosis, " Obesity Surgery, vol. 18, no. 4, pp. 371-377, 2008.
48. R. Kirsch, V. Clarkson, R. C. Verdonk et al., "Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency, " Journal of Gastroenterology and Hepatology, vol. 21, no. 1, part 1, pp. 174-182, 2006.
49. S. H. Zeisel, K. A. DaCosta, M. Youssef, and S. Hensey, "Conversion of dietary choline to trimethylamine and dimethylamine in rats: dose-response relationship, " Journal of Nutrition, vol. 119, no. 5, pp. 800-804, 1989.
50. K. Cope, T. Risby, and A. M. Diehl, "Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis, " Gastroenterology, vol. 119, no. 5, pp. 1340-1347, 2000.